Chi Shing Li
Corporate Officer/Principal at CSL Behring Asia Pacific Ltd.
Profile
Chi Shing Li is currently the Vice President & General Manager at CSL Behring Asia Pacific Ltd.
He was previously the Chief Executive Officer at Quality HealthCare Medical Services Ltd.
from 2012 to 2015.
He also held positions as Director-Pharmaceutical Marketing at Eli Lilly & Company (Taiwan), Inc., Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., and Vice President-Asia Pacific Region at Cephalon, Inc. Mr. Li earned an MBA degree from the University of Macau in 1986.
Chi Shing Li active positions
| Companies | Position | Start |
|---|---|---|
CSL Behring Asia Pacific Ltd.
 CSL Behring Asia Pacific Ltd. Medical DistributorsDistribution Services CSL Behring Asia Pacific Ltd. engages in the research, development, manufacturing, and sale of biological therapies for the treatment of serious and rare conditions. It focuses on plasma protein biotherapeutics. The company was founded on March 6, 2000 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/03/2015 |
Former positions of Chi Shing Li
| Companies | Position | End |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 01/01/2023 |
Quality HealthCare Medical Services Ltd.
 Quality HealthCare Medical Services Ltd. Medical/Nursing ServicesHealth Services Part of The British United Provident Association Ltd., Quality HealthCare Medical Services Ltd. provides contract health care services. The private company is based in Hong Kong, Hong Kong. Quality HealthCare Medical Services was acquired by The British United Provident Association Ltd. from Fortis Healthcare Ltd. on October 24, 2013 for $354.98 million. | Chief Executive Officer | 01/02/2015 |
Eli Lilly & Company (Taiwan), Inc.
 Eli Lilly & Company (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly & Company (Taiwan), Inc. is a Taiwanese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Taipei, Taiwan. | Sales & Marketing | - |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - |
Training of Chi Shing Li
| University of Macau | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
| Private companies | 4 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Quality HealthCare Medical Services Ltd.
Quality HealthCare Medical Services Ltd. Medical/Nursing ServicesHealth Services Part of The British United Provident Association Ltd., Quality HealthCare Medical Services Ltd. provides contract health care services. The private company is based in Hong Kong, Hong Kong. Quality HealthCare Medical Services was acquired by The British United Provident Association Ltd. from Fortis Healthcare Ltd. on October 24, 2013 for $354.98 million. | Health Services |
Eli Lilly & Company (Taiwan), Inc.
Eli Lilly & Company (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly & Company (Taiwan), Inc. is a Taiwanese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Taipei, Taiwan. | Health Technology |
CSL Behring Asia Pacific Ltd.
CSL Behring Asia Pacific Ltd. Medical DistributorsDistribution Services CSL Behring Asia Pacific Ltd. engages in the research, development, manufacturing, and sale of biological therapies for the treatment of serious and rare conditions. It focuses on plasma protein biotherapeutics. The company was founded on March 6, 2000 and is headquartered in Hong Kong. | Distribution Services |
- Stock Market
- Insiders
- Chi Shing Li
